These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 26862008)

  • 21. [Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].
    Calvar CE; Bengolea SV; Hermes R; Loyato M
    Medicina (B Aires); 2007; 67(1):1-7. PubMed ID: 17408014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition.
    Moran LJ; Noakes M; Clifton PM; Wittert GA; Tomlinson L; Galletly C; Luscombe ND; Norman RJ
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3337-44. PubMed ID: 15240612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS.
    Gower BA; Chandler-Laney PC; Ovalle F; Goree LL; Azziz R; Desmond RA; Granger WM; Goss AM; Bates GW
    Clin Endocrinol (Oxf); 2013 Oct; 79(4):550-7. PubMed ID: 23444983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
    Barber TM; Casanueva FF; Karpe F; Lage M; Franks S; McCarthy MI; Wass JA
    Eur J Endocrinol; 2008 Apr; 158(4):511-6. PubMed ID: 18362298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C; Cardoza L; Coutiño B; Hidalgo R; Arteaga-Troncoso G; Parra A
    J Endocrinol; 2005 Jan; 184(1):233-9. PubMed ID: 15642799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.
    Adeniji AA; Essah PA; Nestler JE; Cheang KI
    J Womens Health (Larchmt); 2016 Jun; 25(6):638-45. PubMed ID: 26871978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
    Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
    Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M; Aydemir M; Tuzcu A
    Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The frequency of insulin resistance calculated upon the basis of a fasting glucose to insulin ratio and characteristics of insulin resistant women with polycystic ovary syndrome.
    Popovska-Dimova Z; Krstevska B
    Prilozi; 2006 Jul; 27(1):87-95. PubMed ID: 16985482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative diagnostic characteristics of carbohydrate metabolism disorders in women with polycystic ovary syndrome (PCOS)].
    Orbetsova M; Orbetsova V; Kamenov Z; Kolarov G; Andreeva M; Genchev G; Zakharieva S; Borisov I
    Akush Ginekol (Sofiia); 2003; 42(4):10-5. PubMed ID: 14577361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
    Pérez-Bravo F; Echiburú B; Maliqueo M; Santos JL; Sir-Petermann T
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome.
    Aydin K; Arusoglu G; Koksal G; Cinar N; Aksoy DY; Yildiz BO
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):588-92. PubMed ID: 24730585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial.
    Asemi Z; Samimi M; Tabassi Z; Shakeri H; Sabihi SS; Esmaillzadeh A
    Nutrition; 2014; 30(11-12):1287-93. PubMed ID: 25194966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum insulin patterns and the relationship between insulin sensitivity and glycaemic profile in women with polycystic ovary syndrome.
    Seneviratne HR; Lankeshwara D; Wijeratne S; Somasunderam N; Athukorale D
    BJOG; 2009 Dec; 116(13):1722-8. PubMed ID: 19775306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
    Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study.
    Tagliaferri V; Romualdi D; Guido M; Mancini A; De Cicco S; Di Florio C; Immediata V; Di Segni C; Lanzone A
    Eur J Endocrinol; 2016 Nov; 175(5):433-41. PubMed ID: 27511825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.